Zhejiang Tianyu Pharmaceutical Co Ltd (300702) — Cash Flow-to-Debt Ratio
Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥233.18 Million could theoretically repay 0% of its total liabilities (CN¥2.84 Billion) in one year. See 300702 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Tianyu Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Zhejiang Tianyu Pharmaceutical Co Ltd across 12 annual periods. Also explore 300702 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Zhejiang Tianyu Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Zhejiang Tianyu Pharmaceutical Co Ltd (300702) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | CN¥344.64 Million | CN¥3.08 Billion | ▲ +826.2% |
| 2023 | -0.02x | CN¥-43.90 Million | CN¥2.85 Billion | ▲ +7.6% |
| 2022 | -0.02x | CN¥-48.70 Million | CN¥2.92 Billion | ▲ +86.7% |
| 2021 | -0.13x | CN¥-262.23 Million | CN¥2.09 Billion | ▼ -127.1% |
| 2020 | 0.46x | CN¥622.18 Million | CN¥1.34 Billion | ▼ -13.0% |
| 2019 | 0.53x | CN¥427.84 Million | CN¥803.09 Million | ▲ +702.0% |
| 2018 | 0.07x | CN¥78.57 Million | CN¥1.18 Billion | ▼ -38.5% |
| 2017 | 0.11x | CN¥88.52 Million | CN¥818.99 Million | ▼ -40.4% |
| 2016 | 0.18x | CN¥164.74 Million | CN¥907.72 Million | ▲ +921.9% |
| 2015 | 0.02x | CN¥14.75 Million | CN¥830.58 Million | ▼ -86.1% |
| 2014 | 0.13x | CN¥80.44 Million | CN¥628.67 Million | ▲ +66.8% |
| 2013 | 0.08x | CN¥39.73 Million | CN¥518.11 Million | — |